Colin Tierney participated in a webinar that showcased the benefits of blockchain-enabled solutions.
On June 17th, 2020, Veratrak’s Head of Product, Colin Tierney was invited to sit alongside other technology experts as a panel member to investigate the potential and challenges of blockchain in 2020. Colin was selected as the expert from the pharmaceutical and life sciences industry amongst a panel that included technology experts across multiple industries including energy, financial services, and food & agriculture.
The COVID-19 crisis has caused major disruptions and revealed an opportunity for strengthening collaboration and data exchange in global supply chains. The pharmaceutical supply chain has been in need of a digital update prior to the pandemic and has recently revealed new opportunities where innovative, cloud-based platforms can tackle long-running issues related to unsecure exchange of critical documentation and inefficient processes.
Colin shared how COVID-19 has affected the pharmaceutical industry’s adoption of technology, and specifically from the perspective of Veratrak, a rapid increase in use cases for digital auditing, electronic signatures of sensitive documents, and collaboration in the remote working era that Veratrak has helped become a sought-after solution for the entire supply chain.
Key takeaways from the webinar:
Veratrak is committed to solving these challenges. Get in touch to find out how we can improve collaboration, security, and visibility outside the walls of your business.
Who are we?
Veratrak's documentation management and collaboration platform allows Pharmaceutical Supply Chain companies to better collaborate, increasing security and efficiency. Our practical use of blockchain technology provides a rock solid audit trail of documentation handovers for our customers.